Bioisosterism
Bioisosterism is a rational design strategy in medicinal chemistry that systematically replaces molecular fragments with structurally different but physicochemically similar chemical groups to optimize pharmacological properties while preserving the desired biological activity of a lead compound.
12.4K
Publications
570.4K
Citations
33K
Authors
3.1K
Institutions
Publications per year
2017–2026
703
Parents
12.4K
A molecular light switch for DNA: Ru(bpy)2(dppz)2+
Alan E. Friedman, J.‐C. Chambron, Jean Pierre Sauvage et al. · Journal of the American Chemical Society · 1990 · 1.4K citations
1–5 of 12.4K
33K
37
h-index
27
h-index
23
h-index
23
h-index
21
h-index
1–5 of 33K
3.1K

Centre National de la Recherche Scientifique
Paris, France
37 h-index
339 publications
14.4K citations
Harvard University
Cambridge, United States
31 h-index
105 publications
9.3K citations
The University of Tokyo
Tokyo, Japan
29 h-index
209 publications
9K citations

Kyoto University
Kyoto, Japan
28 h-index
234 publications
9K citations
National Institutes of Health
Bethesda, United States
27 h-index
152 publications
7.1K citations

Vanderbilt University
Nashville, United States
27 h-index
121 publications
6.6K citations

University of Minnesota
Minneapolis, United States
26 h-index
107 publications
5.4K citations
Purdue University West Lafayette
West Lafayette, United States
25 h-index
120 publications
5.9K citations
1–8 of 3.1K
JACS · 3.3K publications · 176.1K citations
159
h-index
654 publications · 42.7K citations
102
h-index
JOC · 2.4K publications · 85.9K citations
96
h-index
526 publications · 29.3K citations
77
h-index
119 publications · 12.3K citations
61
h-index
1–5